Impact of Fecal Microbiota Transplantation on Human Health

Dear Colleagues,

Fecal microbiota transplantation (FMT) consists in the infusion of a feces suspension obtained from a healthy donor into the intestinal tract of a recipient patient. The principle of FMT is the reconstitution of a eubiotic state in an altered intestinal bacterial community or providing potentially protective bacteria against local and systemic pathologies.

Therefore, the restoration of a eubiotic state is not only indicated in intestinal infectious diseases but also in noninfectious diseases. In fact, a normal bacterial community provides protection against an inflammatory status that may have potential systemic effects. Conversely, overexpressed bacterial communities can stimulate inflammatory processes, triggering neurodegenerative disorders such as Parkinson’s disease, amyolateral sclerosis, multiple sclerosis, and autism.

As is evident in the literature, the potential therapeutic options are numerous when considering the capability of FMT to modulate an eventual dysbiotic status, as described in intestinal bowel diseases, cardiovascular diseases, immunity disorders, hepatic encephalopathy, psychiatric conditions, and others.

The aim of this Topic Collection is to provide current and thoughtful scientific evidence of the clinical impact of FMT on human health.

Thus, we especially welcome interventional and observational studies aiming to improve the knowledge of FMT’s effects on systemic health and of its use for the treatment of local and systemic diseases. Review studies, including those that use conceptual frameworks for any of the aforementioned topics, will also be welcomed.

Dr. Luca Masucci
Dr. Gianluca Quaranta
Collection Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the collection website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• fecal microbiota transplantation
• laboratory activity and innovation
• gut microbiota manipulation
• immunity
• basic research
• translational research
• systematic review